Skip to content

To study the effectiveness of nebulised hypertonic saline 3 percent versus 7 percent in acute bronchiolitis in young children.

Effectiveness of nebulised hypertonic saline 3 percente versus 7 percent in acute bronchiolitis in young children: A randomised controlled study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/12/078093
Enrollment
50
Registered
2024-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J210- Acute bronchiolitis due to respiratory syncytial virus

Interventions

Control Intervention1: 3ml of 3 percent hypertonic saline with the combination of nebulised adrenaline[0.1ml/kg/dose in 1 in 10000 solution]: 3 percent hypertonic saline with the combination of nebuli

Sponsors

Dr Shreedhar Giri
Lead Sponsor
DR VIRENDER KUMAR
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Children between 2-24 months of age with acute bronchiolitis (defined as an acute viral infection of the lowe respiratory tract affecting young children between 2 to 24 months and is charecterized by respiratory distress, wheezing and or crackles without any other explanation such as pneumonia or atopy).

Exclusion criteria

Exclusion criteria: Children presenting with 1 Use of bronchiodilators or taken any treatment previously or just before presentation to the hospital. 2 History of congenital heart disease. 3 Immunodeficiency disorders. 4 Patients on mechanical ventilation.

Design outcomes

Primary

MeasureTime frame
Length of stay in hospital.Timepoint: It will be calculated at the time of discharge.

Secondary

MeasureTime frame
Need And Duration Of Oxygen Support.Timepoint: At the time of discharge.

Countries

India

Contacts

Public ContactDr. Shreedhar Giri

Sri Balaji Action Medical Institute

kumar_virender@yahoo.com9810180889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026